DCPH
$32.55
Deciphera Pharmaceuticals
($.46)
(1.39%)
DCPH
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($1.14)
Revenue:  $28.21 Mil
Tuesday
Aug 3
4:20 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when DCPH reports earnings?
Beat
Meet
Miss

Where is DCPH's stock price going from here?
Up
Flat
Down
Stock chart of DCPH
Analysts
Summary of analysts' recommendations for DCPH
Score
Grade
Pivots
Resistance
$34.92
$34.50
$33.75

$33.33

Support
$32.58
$32.16
$31.41
Tweet
Growth
Description
Deciphera Pharmaceuticals, LLC is a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance. Its drug candidate includes DCC-2618, DCC-3014 and Rebastinib which are in clinical stage. Deciphera Pharmaceuticals, LLC is based in WALTHAM, United States.